Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Gusterson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate CancerAnna C Wilkins, Barry Gusterson, Zsolt Szijgyarto, et al.
Cancer Letters|June 17, 2006
BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trialZsofia Kote-Jarai, Trevor J Powles, Gillian Mitchell, et al.
Cell Death and Differentiation|July 23, 2021
De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancerSylvain Lefort, Amal El-Naggar, Susanna Tan, et al.
The Journal of Pathology|April 26, 2013
Dasatinib inhibits mammary tumour development in a genetically engineered mouse modelSaadia A Karim, Helen Creedon, Hitesh Patel, et al.
Cancer Research|April 4, 2002
Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativityMilena Gasco, Alexandra K Bell, Victoria Heath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Gene expression profiling after radiation-induced DNA damage is strongly predictive of BRCA1 mutation carrier statusZsofia Kote-Jarai, Richard D Williams, Nicola Cattini, et al.
NPJ Breast Cancer|March 2, 2021
Unmasking the immune microecology of ductal carcinoma in situ with deep learningPriya Lakshmi Narayanan, Shan E Ahmed Raza, Allison H Hall, et al.
Breast Cancer Research : BCR|November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXAlan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 TrialOtto Metzger Filho, Anita Giobbie-Hurder, Elizabeth Mallon, et al.
Cancer Cell|May 3, 2003
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosisDaniele Bergamaschi, Milena Gasco, Louise Hiller, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate CancerAnna C Wilkins, Barry Gusterson, Zsolt Szijgyarto, et al.
Cancer Letters|June 17, 2006
BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trialZsofia Kote-Jarai, Trevor J Powles, Gillian Mitchell, et al.
Cell Death and Differentiation|July 23, 2021
De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancerSylvain Lefort, Amal El-Naggar, Susanna Tan, et al.
The Journal of Pathology|April 26, 2013
Dasatinib inhibits mammary tumour development in a genetically engineered mouse modelSaadia A Karim, Helen Creedon, Hitesh Patel, et al.
Cancer Research|April 4, 2002
Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativityMilena Gasco, Alexandra K Bell, Victoria Heath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Gene expression profiling after radiation-induced DNA damage is strongly predictive of BRCA1 mutation carrier statusZsofia Kote-Jarai, Richard D Williams, Nicola Cattini, et al.
NPJ Breast Cancer|March 2, 2021
Unmasking the immune microecology of ductal carcinoma in situ with deep learningPriya Lakshmi Narayanan, Shan E Ahmed Raza, Allison H Hall, et al.
Breast Cancer Research : BCR|November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXAlan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 TrialOtto Metzger Filho, Anita Giobbie-Hurder, Elizabeth Mallon, et al.
Cancer Cell|May 3, 2003
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosisDaniele Bergamaschi, Milena Gasco, Louise Hiller, et al.
Pageof 3